Načítá se...
Effects of A-317491, a novel and selective P2X(3)/P2X(2/3) receptor antagonist, on neuropathic, inflammatory and chemogenic nociception following intrathecal and intraplantar administration
1. We have recently reported that systemic delivery of A-317491, the first non-nucleotide antagonist that has high affinity and selectivity for blocking P2X(3) homomeric and P2X(2/3) heteromeric channels, is antinociceptive in rat models of chronic inflammatory and neuropathic pain. In an effort to...
Uloženo v:
| Hlavní autoři: | , , , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2003
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1574160/ https://ncbi.nlm.nih.gov/pubmed/14623769 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjp.0705574 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|